Revvity, Inc. (RVTY): Net Income
$241.20M
Year ended 2025-12-28
$237.55M
Trailing 12 months to 2026-07-05
-24.9%
3-year compound annual growth
-19.8%
5-year compound annual growth
+1.3%
10-year compound annual growth
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-28 | $241.20M | -10.8% | 2026-02-24, From 2024-12-30 |
| 2024-12-29 | $270.38M | -61.0% | 2026-02-24, From 2024-01-01 |
| 2023-12-31 | $693.09M | +21.8% | 2026-02-24, From 2023-01-02 |
| 2023-01-01, Fiscal 2022 | $569.18M | -39.7% | 2025-02-25, From 2022-01-03 |
| 2022-01-02, Fiscal 2021 | $943.16M | +29.6% | 2024-02-27, From 2021-01-04 |
| 2021-01-03, Fiscal 2020 | $727.89M | +219.9% | 2023-03-01, From 2019-12-30 |
| 2019-12-29 | $227.56M | -4.4% | 2022-03-03, From 2018-12-31 |
| 2018-12-30 | $237.93M | -18.7% | 2021-03-02, From 2018-01-01 |
| 2017-12-31 | $292.63M | +24.9% | 2020-02-25, From 2017-01-02 |
| 2017-01-01, Fiscal 2016 | $234.30M | +10.3% | 2019-02-26, From 2016-01-04 |
| 2016-01-03, Fiscal 2015 | $212.43M | +34.6% | 2018-02-27, From 2014-12-29 |
| 2014-12-28 | $157.78M | -5.6% | 2017-02-28, From 2013-12-30 |
| 2013-12-29 | $167.21M | +139.1% | 2016-03-01, From 2012-12-31 |
| 2012-12-30 | $69.94M | +813.7% | 2015-02-24, From 2012-01-02 |
| 2012-01-01, Fiscal 2011 | $7.66M | -98.0% | 2014-02-25, From 2011-01-03 |
| 2011-01-02, Fiscal 2010 | $390.98M | +376.3% | 2013-02-26, From 2010-01-04 |
| 2010-01-03, Fiscal 2009 | $82.08M | n/c | 2012-02-28, From 2008-12-29 |
| 2008-12-28 | $126.41M | n/a | 2011-03-01, From 2007-12-31 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Revvity, Inc. (RVTY) | 2025-12-28 | $241.20M | -10.8% |
| Bio-Rad Laboratories, Inc. (BIO) | 2025-12-31 | $759.90M | n/m |
| Waters Corp (WAT) | 2025-12-31 | $642.63M | +0.8% |
| Bruker Corp (BRKR) | 2025-12-31 | -$8.30M | n/m |
| Mettler Toledo International Inc (MTD) | 2025-12-31 | $869.19M | +0.7% |
| Illumina, Inc. (ILMN) | 2025-12-28 | $850.00M | n/m |
| Avantor, Inc. (AVTR) | 2025-12-31 | -$530.20M | n/m |
| Agilent Technologies, Inc. (A) | 2025-10-31 | $1.30B | +1.1% |
| 10x Genomics, Inc. (TXG) | 2025-12-31 | -$43.54M | n/m |
Compare RVTY, BIO, WAT, BRKR side by side · Screen every company in Laboratory Analytical Instruments ↗